JAMP RASAGILINE DIN 02491982
Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: RASAGILINE (RASAGILINE MESYLATE)
Available to quote
Health Canada record
| Active ingredient(s) | RASAGILINE (RASAGILINE MESYLATE) 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N04BD02 RASAGILINE |
| Original market date | 04-Sep-2020 |
| Current status date | 04-Sep-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RASAGILINE (RASAGILINE MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02514540 | AG-RASAGILINE | ANGITA PHARMA INC. | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02514532 | AG-RASAGILINE | ANGITA PHARMA INC. | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02404680 | APO-RASAGILINE | APOTEX INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02404699 | APO-RASAGILINE | APOTEX INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02489120 | ASN-RASAGILINE | ASCEND LABORATORIES LTD | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02489139 | ASN-RASAGILINE | ASCEND LABORATORIES LTD | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02284642 | AZILECT | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02284650 | AZILECT | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02491974 | JAMP RASAGILINE | JAMP PHARMA CORPORATION | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
| 02533723 | MINT-RASAGILINE | MINT PHARMACEUTICALS INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Approved |
| 02533731 | MINT-RASAGILINE | MINT PHARMACEUTICALS INC | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Approved |
| 02418444 | TEVA-RASAGILINE | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 1 MG | Marketed |
| 02418436 | TEVA-RASAGILINE | TEVA CANADA LIMITED | Tablet | RASAGILINE (RASAGILINE MESYLATE) 0.5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22613 | 2019-09-06 | Abbreviated New Drug Submission (ANDS) |